New Releases from NCBI BookshelfAvatrombopag (Doptelet): CADTH Reimbursement Recommendation: Indication: For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment [Internet].​Avatrombopag (Doptelet): CADTH Reimbursement Recommendation: Indication: For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment [Internet].